# the Influence of Prophylactic and Empirical Anti-fungal Treatment in Severe Sepsis Patients With Perforations

> **NCT02941068** · PHASE2 · COMPLETED · sponsor: **Nanjing PLA General Hospital** · enrollment: 223 (actual)

## Conditions studied

- Intra-abdominal Perforation

## Interventions

- **DRUG:** fluconazole and caspofungin

## Key facts

- **NCT ID:** NCT02941068
- **Lead sponsor:** Nanjing PLA General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2016-06
- **Final completion:** —
- **Target enrollment:** 223 (ACTUAL)
- **Last updated:** 2016-10-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02941068

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02941068, "the Influence of Prophylactic and Empirical Anti-fungal Treatment in Severe Sepsis Patients With Perforations". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02941068. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*